Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-29

FDA Approved: CORTISPORIN TC — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cortisporin TC, a four-ingredient otic preparation, under Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CORTISPORIN TC (Colistin sulfate; Neomycin sulfate; Thonzonium bromide; Hydrocortisone acetate)

Snippet

SUPPL AP for CORTISPORIN TC (COLISTIN SULFATE, NEOMYCIN SULFATE, THONZONIUM BROMIDE AND HYDROCORTISONE ACETATE)